This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Yeditepe Üniversitesi. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Eslam Mohammed: Innovator in Cancer Treatment
Introduction
Eslam Mohammed is a notable inventor based in Istanbul, Turkey. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cancer. His innovative work focuses on targeting specific enzymes that play a role in cancer progression.
Latest Patents
Eslam Mohammed holds a patent for a compound titled "2-(3-(2-methyl-6-(p-tolyl) pyridine-3-yl) ureido) benzenesulfonamide and derivatives as inhibitor of carbonic anhydrase IX for the treatment of cancer." This compound is designed to inhibit carbonic anhydrase activity, which is crucial in the treatment and prevention of proliferative diseases, including cancer. The patent highlights the potential of this small molecule as a pharmaceutical agent.
Career Highlights
Eslam Mohammed is affiliated with Yeditepe University, where he continues to engage in research and development. His work is characterized by a commitment to advancing medical science and improving treatment options for patients suffering from cancer.
Collaborations
Eslam collaborates with esteemed colleagues, including Fikrettin Sahin and Meltem Celik. Their combined expertise enhances the research efforts and innovation within their field.
Conclusion
Eslam Mohammed's contributions to cancer treatment through his patented inventions demonstrate his dedication to improving healthcare outcomes. His work exemplifies the impact of innovative research in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile